News dal mondo
COVID-19 to setback blockchain implementation in global pharmaceutical supply chains
Even though blockchain stands out as a potential solution to improve pharmaceutical supply chains, COVID-19 may become a hindrance rather than a trigger in the technology’s future implementation...
Eight Global Pharmaceutical Companies Show Interest in India’s API Expansion Plan
India’s plan to draw foreign majors to ramp up production of active pharmaceutical ingredients (APIs) has drawn interest from eight companies as it mulls extending sops to existing domestic entities...
EMA explains GMP and GDP flexibilities amid COVID-19
The European Medicines Agency (EMA) and its counterparts at the European Commission and Heads of Medicines Agencies have updated their questions and answers guidance on regulatory expectations for medicinal...
No Near-Term Impact on Chinese API Makers as Pharma Supply-Chain Shifts
Chinese active pharmaceutical ingredient (API) makers are unlikely to be significantly affected in the medium term by increasing trade protectionism and customer moves to reduce dependence on supplies...